Clinical Trials
3 trialsNCT07124000 2026-06-01
DP-04
AstraZeneca
Recruiting
NCT07012031 2026-05-13
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
National Cancer Institute (NCI)
Phase 1/2 Recruiting
NCT05246514 2026-05-12
DL-05
AstraZeneca
Phase 2 Active not recruiting